These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 35761367)

  • 1. The high-volume haemodiafiltration vs high-flux haemodialysis registry trial (H4RT): a multi-centre, unblinded, randomised, parallel-group, superiority study to compare the effectiveness and cost-effectiveness of high-volume haemodiafiltration and high-flux haemodialysis in people with kidney failure on maintenance dialysis using linkage to routine healthcare databases for outcomes.
    Caskey FJ; Procter S; MacNeill SJ; Wade J; Taylor J; Rooshenas L; Liu Y; Annaw A; Alloway K; Davenport A; Power A; Farrington K; Mitra S; Wheeler DC; Law K; Lewis-White H; Ben-Shlomo Y; Hollingworth W; Donovan J; Lane JA
    Trials; 2022 Jun; 23(1):532. PubMed ID: 35761367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefits and harms of high-dose haemodiafiltration versus high-flux haemodialysis: the comparison of high-dose haemodiafiltration with high-flux haemodialysis (CONVINCE) trial protocol.
    Blankestijn PJ; Fischer KI; Barth C; Cromm K; Canaud B; Davenport A; Grobbee DE; Hegbrant J; Roes KC; Rose M; Strippoli GF; Vernooij RW; Woodward M; de Wit GA; Bots ML
    BMJ Open; 2020 Feb; 10(2):e033228. PubMed ID: 32029487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of haemodiafiltration vs conventional haemodialysis on growth and cardiovascular outcomes in children - the HDF, heart and height (3H) study.
    Shroff R; Bayazit A; Stefanidis CJ; Askiti V; Azukaitis K; Canpolat N; Agbas A; Anarat A; Aoun B; Bakkaloglu S; Bhowruth D; Borzych-Dużałka D; Bulut IK; Büscher R; Dempster C; Duzova A; Habbig S; Hayes W; Hegde S; Krid S; Licht C; Litwin M; Mayes M; Mir S; Nemec R; Obrycki L; Paglialonga F; Picca S; Ranchin B; Samaille C; Shenoy M; Sinha M; Smith C; Spasojevic B; Vidal E; Vondrák K; Yilmaz A; Zaloszyc A; Fischbach M; Schaefer F; Schmitt CP
    BMC Nephrol; 2018 Aug; 19(1):199. PubMed ID: 30097064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemodiafiltration and mortality in end-stage kidney disease patients: a pooled individual participant data analysis from four randomized controlled trials.
    Peters SA; Bots ML; Canaud B; Davenport A; Grooteman MP; Kircelli F; Locatelli F; Maduell F; Morena M; Nubé MJ; Ok E; Torres F; Woodward M; Blankestijn PJ;
    Nephrol Dial Transplant; 2016 Jun; 31(6):978-84. PubMed ID: 26492924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemodiafiltration, haemofiltration and haemodialysis for end-stage kidney disease.
    Nistor I; Palmer SC; Craig JC; Saglimbene V; Vecchio M; Covic A; Strippoli GF
    Cochrane Database Syst Rev; 2015 May; 2015(5):CD006258. PubMed ID: 25993563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality and cardiovascular events in online haemodiafiltration (OL-HDF) compared with high-flux dialysis: results from the Turkish OL-HDF Study.
    Ok E; Asci G; Toz H; Ok ES; Kircelli F; Yilmaz M; Hur E; Demirci MS; Demirci C; Duman S; Basci A; Adam SM; Isik IO; Zengin M; Suleymanlar G; Yilmaz ME; Ozkahya M;
    Nephrol Dial Transplant; 2013 Jan; 28(1):192-202. PubMed ID: 23229932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Randomized, Single-Blind, Crossover Trial of Recovery Time in High-Flux Hemodialysis and Hemodiafiltration.
    Smith JR; Zimmer N; Bell E; Francq BG; McConnachie A; Mactier R
    Am J Kidney Dis; 2017 Jun; 69(6):762-770. PubMed ID: 28024931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and methodology of the impact of HemoDiaFIlTration on physical activity and self-reported outcomes: a randomized controlled trial (HDFIT trial) in Brazil.
    Pecoits-Filho R; Larkin JW; Poli-de-Figueiredo CE; Cuvello Neto AL; Barra AB; Canhada S; de Campos LG; Woehl J; Gonçalves PB; Han H; de Moraes TP; Raimann JG; Canziani MEF;
    BMC Nephrol; 2019 Mar; 20(1):98. PubMed ID: 30894141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The probability of receiving a kidney transplantation in end-stage kidney disease patients who are treated with haemodiafiltration or haemodialysis: a pooled individual participant data from four randomised controlled trials.
    Vernooij RWM; Law W; Peters SAE; Canaud B; Davenport A; Grooteman MPC; Kircelli F; Locatelli F; Maduell F; Morena M; Nubé MJ; Ok E; Torres F; Woodward M; Blankestijn PJ; Bots ML;
    BMC Nephrol; 2021 Feb; 22(1):70. PubMed ID: 33632160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-efficiency on-line haemodiafiltration improves conduit artery endothelial function compared with high-flux haemodialysis in end-stage renal disease patients.
    Bellien J; Fréguin-Bouilland C; Joannidès R; Hanoy M; Rémy-Jouet I; Monteil C; Iacob M; Martin L; Renet S; Vendeville C; Godin M; Thuillez C; Le Roy F
    Nephrol Dial Transplant; 2014 Feb; 29(2):414-22. PubMed ID: 24235073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CONVINCE in the context of existing evidence on haemodiafiltration.
    Vernooij RWM; Bots ML; Strippoli GFM; Canaud B; Cromm K; Woodward M; Blankestijn PJ;
    Nephrol Dial Transplant; 2022 May; 37(6):1006-1013. PubMed ID: 35098994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On-line haemodiafiltration versus low-flux haemodialysis. A prospective randomized study.
    Wizemann V; Lotz C; Techert F; Uthoff S
    Nephrol Dial Transplant; 2000; 15 Suppl 1():43-8. PubMed ID: 10737166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of procoagulatory activity of haemodialysis, haemofiltration and haemodiafiltration with a polysulfone membrane (APS) and with different modes of enoxaparin anticoagulation.
    Klingel R; Schaefer M; Schwarting A; Himmelsbach F; Altes U; Uhlenbusch-Körwer I; Hafner G
    Nephrol Dial Transplant; 2004 Jan; 19(1):164-70. PubMed ID: 14671052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is hemodiafiltration superior to high-flow hemodialysis in reducing all-cause and cardiovascular mortality in kidney failure patients? A meta-analysis of randomized controlled trials.
    Bignardi PR; Delfino VDA
    Hemodial Int; 2024 Apr; 28(2):139-147. PubMed ID: 38369730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of high-volume online haemodiafiltration on nutritional status and body composition: the ProtEin Stores prEservaTion (PESET) study.
    Molina P; Vizcaíno B; Molina MD; Beltrán S; González-Moya M; Mora A; Castro-Alonso C; Kanter J; Ávila AI; Górriz JL; Estañ N; Pallardó LM; Fouque D; Carrero JJ
    Nephrol Dial Transplant; 2018 Jul; 33(7):1223-1235. PubMed ID: 29370428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemodiafiltration, haemofiltration and haemodialysis for end-stage kidney disease.
    Rabindranath KS; Strippoli GF; Daly C; Roderick PJ; Wallace S; MacLeod AM
    Cochrane Database Syst Rev; 2006 Oct; (4):CD006258. PubMed ID: 17054289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemodiafiltration does not lower protein-bound uraemic toxin levels compared with haemodialysis in a paediatric population.
    Snauwaert E; Van Biesen W; Raes A; Glorieux G; Vande Walle J; Roels S; Vanholder R; Askiti V; Azukaitis K; Bayazit A; Canpolat N; Fischbach M; Saoussen K; Litwin M; Obrycki L; Paglialonga F; Ranchin B; Samaille C; Schaefer F; Schmitt CP; Spasojevic B; Stefanidis CJ; Shroff R; Eloot S
    Nephrol Dial Transplant; 2020 Apr; 35(4):648-656. PubMed ID: 31361315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomised, open-label, multicentre trial comparing haemodialysis plus haemoperfusion versus haemodialysis alone in adult patients with end-stage renal disease (HD/HP vs HD): study protocol.
    Lu W; Jiang GR;
    BMJ Open; 2018 Jul; 8(7):e022169. PubMed ID: 30056391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cost-utility of haemodiafiltration versus haemodialysis in the Convective Transport Study.
    Mazairac AH; Blankestijn PJ; Grooteman MP; Penne EL; van der Weerd NC; den Hoedt CH; Buskens E; van den Dorpel MA; ter Wee PM; Nubé MJ; Bots ML; de Wit GA;
    Nephrol Dial Transplant; 2013 Jul; 28(7):1865-73. PubMed ID: 23766337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exercise programme to improve quality of life for patients with end-stage kidney disease receiving haemodialysis: the PEDAL RCT.
    Greenwood SA; Koufaki P; Macdonald JH; Bulley C; Bhandari S; Burton JO; Dasgupta I; Farrington K; Ford I; Kalra PA; Kumwenda M; Macdougall IC; Messow CM; Mitra S; Reid C; Smith AC; Taal MW; Thomson PC; Wheeler DC; White C; Yaqoob M; Mercer TH
    Health Technol Assess; 2021 Jun; 25(40):1-52. PubMed ID: 34156335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.